Vascular effects of cardiotrophin-1: A role in hypertension?

Journal of Hypertension

Volumn 28, Issue 6, 2010, Pages 1261-1272

  Lopez Andres, Natalia ^a   Fortuno, Maria A ^b   Diez, Javier ^b,c   Zannad, Faiez ^a,d   Lacolley, Patrick ^a   Rossignol, Patrick ^a,d  

^a INSERM   (France)

^b Centre for Applied Medical Research   (Australia)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d Ctr Hospitalier Univ de Nancy   (France)

Author keywords

Aldosterone; Arterial remodeling; Cardiotrophin 1; Hypertension

Indexed keywords

CARDIOTROPHIN 1; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; MESSENGER RNA; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; STAT3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HYPERTENSION; HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 77952544972     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328337fe42     Document Type: Article

References (27)

1. Mulvany MJ. Small artery remodeling in hypertension. Curr Hypertens Rep 2002; 4:49-55.
2. Campbell GR, Campbell JH. The phenotypes of smooth muscle expressed in human atheroma. Ann N Y Acad Sci 1990; 598:143-158.
3. Thie M, Harrach B, Schonherr E, Kresse H, Robenek H, Rauterberg J. Responsiveness of aortic smooth muscle cells to soluble growth mediators is influenced by cell-matrix contact. Arterioscler Thromb 1993; 13:994-1004.
4. Fasnacht N, Muller W. Conditional gp130 deficient mouse mutants. Semin Cell Dev Biol 2008; 19:379-384.
5. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 1991; 260:H1713-H1717.
6. Wang Z, Newman WH. Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization. J Surg Res 2003; 111:261-266.
7. Demyanets S, Kaun C, Rychli K, Rega G, Pfaffenberger S, Afonyushkin T, et al. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways. AmJPhysiol Heart Circ Physiol 2007; 293:H1962-H1968.
8. Rolfe BE, Stamatiou S, World CJ, Brown L, Thomas AC, Bingley JA, et al. Leukaemia inhibitory factor retards the progression of atherosclerosis. Cardiovasc Res 2003; 58:222-230.
9. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995; 92:1142-1146.
10. Lopez N, Diez J, Fortuno MA. Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats. J Mol Cell Cardiol 2006; 41:902-913.
11. Tsuruda T, Jougasaki M, Boerrigter G, Huntley BK, Chen HH, D'Assoro AB, et al. Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res 2002; 90:128-134.
12. Yang ZF, Lau CK, Ngai P, Lam SP, Ho DW, Poon RT, Fan ST. Cardiotrophin-1 enhances regeneration of cirrhotic liver remnant after hepatectomy through promotion of angiogenesis and cell proliferation. Liver Int 2008; 28:622-631.
13. Zhou D, Zheng X, Wang L, Stelmack G, Halayko AJ, Dorscheid D, Bai TR. Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells. Br J Pharmacol 2003; 140:1237-1244.
14. Jougasaki M, Larsen AM, Cataliotti A, Christiansen DC, Burnett JC Jr. Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells. Peptides 2002; 23:1441-1447.
15. Ichiki T, Jougasaki M, Setoguchi M, Imamura J, Nakashima H, Matsuoka T, et al. Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. Am J Physiol Heart Circ Physiol 2008; 294:H750-H763.
16. Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E, et al. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens 1999; 17:807-816.
17. Lopez B, Gonzalez A, Lasarte JJ, Sarobe P, Borras F, Diaz A, et al. Is plasma cardiotrophin-1 a marker of hypertensive heart disease? J Hypertens 2005; 23:625-632. (Pubitemid 40684722)
18. Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res 2005; 68:109-117.
19. Gonzalez A, Lopez B, Martin-Raymondi D, Lozano E, Varo N, Barba J, et al. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J Hypertens 2005; 23:2297-2304.
20. Rossignol P, Bouton MC, Jandrot-Perrus M, Bryckaert M, Jacob MP, Bezeaud A, et al. A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp Cell Res 2004; 299:279-285.
21. Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, et al. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 2006; 99:1181-1187.
22. Rossignol P, Luttun A, Martin-Ventura JL, Lupu F, Carmeliet P, Collen D, et al. Plasminogen activation: a mediator of vascular smooth muscle cell apoptosisinatheroscleroticplaques.JThromb Haemost 2006;4:664-670.
23. Lopez N, Varo N, Diez J, Fortuno MA. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? Cardiovasc Res 2007; 75:536-545.
24. El Mabrouk M, Touyz RM, Schiffrin EL. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol 2001; 281:H30-H39.
25. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43:838-849.
26. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351:33-41.
27. Lopez-Andres N, Inigo C, Gallego I, Diez J, Fortuno MA. Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes. Endocrinology 2008; 149:4970-4978.